Page last updated: 2024-08-18

pyrroles and Pyrosis

pyrroles has been researched along with Pyrosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Deguchi, H; Fernandez, J; Fujimori, I; Igarashi, A; Nakano, H; Oshima, T1
Armstrong, D; Fass, R; Harris, T; Hunt, B; Leifke, E; Sharma, P; Smith, N; Vaezi, M; Yadlapati, R1
Araki, T; Ashida, K; Iwakiri, K; Kinoshita, Y; Kudou, K; Miyagi, T; Sakurai, Y; Takabayashi, N1
Cheng, Y; Dai, Y; Jiang, H; Kou, F; Li, J; Li, X; Liu, J; Lu, Q; Tan, X; Xie, C1
Ashida, K; Hiramatsu, N; Hori, T; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E1
Arai, E; Fukui, H; Kondo, T; Miwa, H; Oshima, T; Taki, M; Tomita, T; Watari, J1
Kondo, T; Miwa, H; Oshima, T1

Reviews

3 review(s) available for pyrroles and Pyrosis

ArticleYear
Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis.
    Journal of clinical gastroenterology, 2022, 07-01, Volume: 56, Issue:6

    Topics: Adult; Bayes Theorem; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Network Meta-Analysis; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome

2022
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
    Digestive diseases and sciences, 2021, Volume: 66, Issue:1

    Topics: Gastroesophageal Reflux; Heartburn; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome

2021
Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.
    Current opinion in gastroenterology, 2016, Volume: 32, Issue:4

    Topics: Esophageal pH Monitoring; Esophagus; Gastric Acidity Determination; Gastroesophageal Reflux; Heartburn; Humans; Mucous Membrane; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2016

Trials

4 trial(s) available for pyrroles and Pyrosis

ArticleYear
Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease.
    Alimentary pharmacology & therapeutics, 2023, Volume: 58, Issue:10

    Topics: Gastroesophageal Reflux; Heartburn; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2023
Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
    Clinical and translational gastroenterology, 2019, Volume: 10, Issue:11

    Topics: Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Pyrroles; Sulfonamides; Treatment Outcome

2019
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
    World journal of gastroenterology, 2018, Apr-14, Volume: 24, Issue:14

    Topics: Adult; Aged; Biopsy; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Gastric Mucosa; Gastroesophageal Reflux; Heartburn; Humans; Incidence; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Recurrence; Sulfonamides; Treatment Outcome

2018
Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:2

    Topics: Adult; Aged; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2019